Tahara K - Search Results

1

Intracellular drug delivery using polysorbate 80-modified poly(D,L-lactide-co-glycolide) nanospheres to glioblastoma cells.

Tahara K, Kato Y, Yamamoto H, Kreuter J, Kawashima Y. Tahara K, et al. J Microencapsul. 2011;28(1):29-36. doi: 10.3109/02652048.2010.522258. J Microencapsul. 2011. PMID: 21171814

2

[Development of gene delivery system using PLGA nanospheres].

Tahara K, Yamamoto H, Takeuchi H, Kawashima Y. Tahara K, et al. Yakugaku Zasshi. 2007 Oct;127(10):1541-8. doi: 10.1248/yakushi.127.1541. Yakugaku Zasshi. 2007. PMID: 17917416 Review. Japanese.

3

Establishing chitosan coated PLGA nanosphere platform loaded with wide variety of nucleic acid by complexation with cationic compound for gene delivery.

Tahara K, Sakai T, Yamamoto H, Takeuchi H, Kawashima Y. Tahara K, et al. Int J Pharm. 2008 Apr 16;354(1-2):210-6. doi: 10.1016/j.ijpharm.2007.11.002. Epub 2007 Nov 9. Int J Pharm. 2008. PMID: 18178349

4

Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells.

Tahara K, Sakai T, Yamamoto H, Takeuchi H, Hirashima N, Kawashima Y. Tahara K, et al. Int J Pharm. 2009 Dec 1;382(1-2):198-204. doi: 10.1016/j.ijpharm.2009.07.023. Epub 2009 Jul 29. Int J Pharm. 2009. PMID: 19646519

5

Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for improving siRNA delivery and gene-silencing effects.

Tahara K, Yamamoto H, Hirashima N, Kawashima Y. Tahara K, et al. Eur J Pharm Biopharm. 2010 Mar;74(3):421-6. doi: 10.1016/j.ejpb.2009.12.007. Epub 2009 Dec 23. Eur J Pharm Biopharm. 2010. PMID: 20034563 Free PMC article.

6

Cellular uptake mechanisms and intracellular distributions of polysorbate 80-modified poly (D,L-lactide-co-glycolide) nanospheres for gene delivery.

Tahara K, Yamamoto H, Kawashima Y. Tahara K, et al. Eur J Pharm Biopharm. 2010 Jun;75(2):218-24. doi: 10.1016/j.ejpb.2010.03.013. Epub 2010 Mar 21. Eur J Pharm Biopharm. 2010. PMID: 20332026

7

Hybrid-modified poly(D,L-lactide-co-glycolide) nanospheres for a novel cellular drug delivery system.

Tahara K, Furukawa S, Yamamoto H, Kawashima Y. Tahara K, et al. Int J Pharm. 2010 Jun 15;392(1-2):311-3. doi: 10.1016/j.ijpharm.2010.03.042. Epub 2010 Mar 25. Int J Pharm. 2010. PMID: 20347023

8

Oral nuclear factor-κB decoy oligonucleotides delivery system with chitosan modified poly(D,L-lactide-co-glycolide) nanospheres for inflammatory bowel disease.

Tahara K, Samura S, Tsuji K, Yamamoto H, Tsukada Y, Bando Y, Tsujimoto H, Morishita R, Kawashima Y. Tahara K, et al. Biomaterials. 2011 Jan;32(3):870-8. doi: 10.1016/j.biomaterials.2010.09.034. Biomaterials. 2011. PMID: 20934748

9

Brain targeting with surface-modified poly(D,L-lactic-co-glycolic acid) nanoparticles delivered via carotid artery administration.

Tahara K, Miyazaki Y, Kawashima Y, Kreuter J, Yamamoto H. Tahara K, et al. Eur J Pharm Biopharm. 2011 Jan;77(1):84-8. doi: 10.1016/j.ejpb.2010.11.002. Epub 2010 Nov 11. Eur J Pharm Biopharm. 2011. PMID: 21074612

10

Improvements in transfection efficiency with chitosan modified poly(DL-lactide-co-glycolide) nanospheres prepared by the emulsion solvent diffusion method, for gene delivery.

Tahara K, Sakai T, Yamamoto H, Takeuchi H, Hirashima N, Kawashima Y. Tahara K, et al. Chem Pharm Bull (Tokyo). 2011;59(3):298-301. doi: 10.1248/cpb.59.298. Chem Pharm Bull (Tokyo). 2011. PMID: 21372409

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results